Related Experiment Videos

Experimental production of arachnoiditis with water-soluble myelographic media

Radiology
|June 1, 1977
PubMed

Insights

Myelography using metrizamide or meglumine iocarmate in primates can cause arachnoid fibrosis. Lower concentrations and volumes of water-soluble contrast media may minimize the risk of arachnoiditis.

Area of Science:

  • Radiology and Imaging
  • Neuroscience
  • Comparative Pathology

Background:

  • Myelography is a diagnostic imaging procedure used to visualize the spinal canal.
  • Water-soluble contrast media are commonly employed, but potential adverse effects like arachnoiditis are a concern.

Purpose of the Study:

  • To evaluate the risk of arachnoiditis following myelography with different contrast agents and concentrations in a primate model.
  • To determine factors influencing the development of arachnoid fibrosis after myelography.

Main Methods:

  • Primates underwent myelography using metrizamide or meglumine iocarmate at specified concentrations.
  • Radiographic and histological analyses were performed to assess the degree of arachnoid fibrosis.
  • Comparative analysis included intrathecal injections of lower concentration metrizamide and autologous cerebrospinal fluid.

Main Results:

  • Mild to severe arachnoid fibrosis was observed after myelography with higher concentrations of metrizamide and meglumine iocarmate.
  • Lower concentrations of metrizamide and autologous cerebrospinal fluid resulted in less pronounced arachnoiditis.
  • The primate model demonstrated reliability for controlled studies on myelography-induced arachnoiditis.

Conclusions:

  • The risk of arachnoiditis following myelography is associated with the concentration and volume of water-soluble contrast media used.
  • Reducing contrast agent concentration and volume may mitigate the incidence and severity of arachnoid fibrosis.
  • Primates serve as a suitable model for investigating arachnoiditis complications of myelography.

Related Concept Videos